DMTRF (3-D Matrix) Other Financing: $0.00 Mil (TTM As of Jan. 2026)


DMTRF 3-D Matrix Ltd DMTRF
55 GF Score
Price $2.25
GF Value $1.92
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is 3-D Matrix Other Financing?

3-D Matrix DMTRF 55 Other Financing is $0.00 Mil as of Jan. 2026. GuruFocus rates DMTRF with a GF Score™ of 55/100 and a GF Value™ of $1.92 (Fairly Valued). The stock has 3 warning signs investors should review.

3-D Matrix's Other Financing for the three months ended in Jan. 2026 was $0.00 Mil.

3-D Matrix's Other Financing for the trailing twelve months (TTM) ended in Jan. 2026 was $0.00 Mil.

3-D Matrix Other Financing Historical Data

* Premium members only.

The historical data trend for 3-D Matrix's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3-D Matrix Other Financing Chart

3-D Matrix Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.01 0.10 -0.02 -7.00

3-D Matrix Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DMTRF
55GF Score
3-D Matrix Ltd DMTRF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

3-D Matrix Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $0.00 Mil mean?
3-D Matrix (DMTRF) has a Other Financing of $0.00 Mil as of Jan. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for 3-D Matrix and its competitors.
Is 3-D Matrix's Other Financing too high?
3-D Matrix's current Other Financing is $0.00 Mil. Overall, 3-D Matrix has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does 3-D Matrix's Other Financing compare to ABT and SYK?
3-D Matrix's Other Financing of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for 3-D Matrix and its competitors. 3-D Matrix's current Other Financing is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3-D Matrix stock overvalued right now?
Based on GuruFocus' analysis, 3-D Matrix (DMTRF) is currently considered Fairly Valued. The stock's GF Value™ is $1.92, compared to a current price of $2.25 — trading 17.2% above its estimated fair value. The current Other Financing is $0.00 Mil. 3-D Matrix's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For 3-D Matrix (DMTRF), the current Other Financing is $0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3-D Matrix (DMTRF) Overvalued in 2026?

Based on GuruFocus' analysis, 3-D Matrix stock appears to be overvalued. The current stock price of $2.25 is trading 17.2% above its estimated GF Value™ of $1.92. GuruFocus considers 3-D Matrix to be Fairly Valued.

Key valuation signals for DMTRF:

  • Other Financing: $0.00 Mil
  • GF Value™: $1.92 vs. price of $2.25 (17.2% above fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the DMTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3-D Matrix Business Description

Other Exchanges 7777:Japan
Address 3-2-4 Kojimachi, Chiyoda-ku, 7th floor, Kojimachi HF Building, Tokyo, JPN, 102-0083
3-D Matrix Ltd is engaged in the research, development, manufacture, and sale of medical devices based on the self-assembling peptide technology. Its products include PuraMatrix, High Concentration PuraMatrix, Modified Peptide and GMP Grade PuraMatrix.
55GF Score

Get the complete analysis for DMTRF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.25
Price
$1.92
GF Value